These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28112585)

  • 1. Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay.
    Gibson ML; Hohmeier KC; Smith CT
    Pharmacogenomics; 2017 Feb; 18(3):227-233. PubMed ID: 28112585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' knowledge and attitude towards therapeutic reference pricing system in Slovenia.
    Marđetko N; Kos M
    Int J Clin Pharm; 2016 Oct; 38(5):1301-10. PubMed ID: 27503281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' needs and interests in a self-pay medication therapy management service.
    Friedrich M; Zgarrick D; Masood A; Montuoro J
    J Am Pharm Assoc (2003); 2010; 50(1):72-7. PubMed ID: 20097642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' willingness to pay for cognitive pharmacist services in community pharmacies.
    Lakić D; Stević I; Odalović M; Vezmar-Kovačević S; Tadić I
    Croat Med J; 2017 Oct; 58(5):364-371. PubMed ID: 29094815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient valuation of pharmacist services for self care with OTC medications.
    Hong SH; Spadaro D; West D; Tak SH
    J Clin Pharm Ther; 2005 Jun; 30(3):193-9. PubMed ID: 15896235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public perceptions of pharmacogenomic services in Ireland - Are people with chronic disease more likely to want service availability than those without? A questionnaire study.
    O'Shea J; Ryan C; Gallagher J; O'Brien C; Morris C; Dwyer E; Laughlin JM; Fitzpatrick L; O'Meara M; Kelly S; Knox S; Ledwidge M
    Explor Res Clin Soc Pharm; 2022 Dec; 8():100182. PubMed ID: 36200068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact and feasibility of a community pharmacy bone mineral density screening and education program.
    Cerulli J; Zeolla MM
    J Am Pharm Assoc (2003); 2004; 44(2):161-7. PubMed ID: 15098850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and evaluation of a serum cholesterol monitoring service in a community pharmacy.
    Einarson TR; Bootman JL; McGhan WF; Larson LN; Gardner ME; Donohue M
    Drug Intell Clin Pharm; 1988 Jan; 22(1):45-8. PubMed ID: 3349919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' willingness to use a pharmacist-provided medication management service: the influence of outcome expectancies and communication efficacy.
    Carter SR; Moles R; White L; Chen TF
    Res Social Adm Pharm; 2012; 8(6):487-98. PubMed ID: 22381916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.
    Haga SB; Moaddeb J; Mills R; Voora D
    Pharmacogenomics; 2017 Mar; 18(4):327-335. PubMed ID: 28244804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needs assessment study for community pharmacy travel medicine services.
    Hind CA; Bond CM; Lee AJ; van Teijlingen ER
    J Travel Med; 2008; 15(5):328-34. PubMed ID: 19006506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumer perceptions of and willingness-to-pay for point-of-care testing services in the community pharmacy.
    Hohmeier KC; Loomis B; Gatwood J
    Res Social Adm Pharm; 2018 Apr; 14(4):360-366. PubMed ID: 28457907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perceptions of a pharmacist-managed weight management clinic in a community setting.
    O'Neal KS; Crosby KM
    Res Social Adm Pharm; 2013; 9(1):129-36. PubMed ID: 22695218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sociodemographic factors and beliefs about medicines in the uptake of pharmacogenomic testing in older adults.
    Chapdelaine A; Lamoureux-Lamarche C; Poder TG; Vasiliadis HM
    Pharmacogenomics; 2021 Feb; 22(3):125-135. PubMed ID: 33601907
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of strategic planning education on attitudes and perceptions of independent community pharmacy owners/managers.
    Harrison DL
    J Am Pharm Assoc (2003); 2007; 47(5):599-604. PubMed ID: 17848349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charitable pharmacy services: Impact on patient-reported hospital use, medication access, and health status.
    Fahey Babeaux HP; Hall LE; Seifert JL
    J Am Pharm Assoc (2003); 2015; 55(1):59-66. PubMed ID: 25575150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicians' perceptions of pharmacogenomics use in psychiatry.
    Chan CY; Chua BY; Subramaniam M; Suen EL; Lee J
    Pharmacogenomics; 2017 Apr; 18(6):531-538. PubMed ID: 28290747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.